Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Propranolol on the Prognosis of Patients With Decompensated Cirrhosis and MELD Score > 9: a Non-inferiority Randomized Controlled Trial

NCT07652203 is registered in ClinicalTrials.gov with General Hospital of Shenyang Military Region as lead sponsor.

NCT NCT07652203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07652203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Propranolol on the Prognosis of Patients With Decompensated Cirrhosis and MELD Score > 9: a Non-inferiority Randomized Controlled Trial
Lead sponsor
General Hospital of Shenyang Military Region
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
July 31, 2028
Enrollment
466 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis